Edition:
United States

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

41.46USD
10 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$41.46
Open
$38.30
Day's High
$41.53
Day's Low
$38.18
Volume
267,334
Avg. Vol
210,492
52-wk High
$96.51
52-wk Low
$35.80

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 10.71 -1.263
Jun '18 25.18 2.071
Mar '18 15.68 -1.252
FY 2017 Dec '17 7.41 -1.745
Sep '17 1.90 -1.898
Jun '17 1.48 -2.401
Mar '17 1.27 -1.699
FY 2016 Dec '16 16.30 -1.205
Sep '16 1.30 -1.072
Jun '16 1.29 -1.044
Mar '16 1.29 -0.954
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 18 30.25 59.80 11.40 42.85
Quarter Ending Mar-19 11 21.31 36.20 11.65 44.57
Year Ending Dec-18 20 81.27 119.89 60.90 94.54
Year Ending Dec-19 20 110.40 157.06 65.24 259.44
Earnings (per share)
Quarter Ending Dec-18 20 -1.03 -0.12 -1.79 -1.15
Quarter Ending Mar-19 11 -1.21 -0.80 -1.70 -0.98
Year Ending Dec-18 17 -1.49 -0.43 -3.40 -5.56
Year Ending Dec-19 21 -4.54 -1.69 -6.40 -1.96
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) 153.83 116.41 5.77
Price to Book (MRQ) 11.96 15.60 5.12
Price to Tangible Book (MRQ) 13.80 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 83.26 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 15.10 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -3.39 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -129.91 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -116.29 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 6.09 5.42 3.11
LT Debt to Equity (MRQ) 0.47 33.58 11.47
Total Debt to Equity (MRQ) 0.60 35.41 15.63
Interest Coverage (TTM) -- -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -816.79 -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -984.26 -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -973.11 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -962.76 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 95,602 25,687,363 898,926,015
Net Income/Employee (TTM) -920,417 2,194,067 106,550,787
Receivable Turnover (TTM) 6.52 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.06 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.26 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -61.15 0.28 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -63.88 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -8.52 -- --
EPS (TTM) % -104.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spark Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.35 2.68 99 57
13 Week 41.42 34.53 99 62
26 Week 71.05 58.05 99 81
52 Week 44.55 22.52 99 47
YTD 75.23 53.89 99 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 265
Total Shares Held: 40,207,738
3 Mo. Net Change: 691,998
# New Positions: 29
# Closed Positions: 27
# Increased Positions: 115
# Reduced Positions: 101
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.